FACT SHEET

Precision HCP targeting and activation

Dynamic LeadGen provides timely, high-quality HCP leads for your field force by leveraging predictive modeling, algorithmic triggers, and programmatic media to maximize the ROI from your data investment.

Supported by end-to-end measurement and “always on" analytics, Dynamic LeadGen is the only solution on the market that finds rare and specialty disease patients through a comprehensive approach - resulting in higher yield than traditional trigger programs.

HOW IT WORKS

Ambit's team of data scientists train and validate ML/AI models using a cohort of diagnosed patients to uncover referral patterns and identify new potential patients who share characteristics of known patients. Similarly, Dynamic LeadGen extracts incremental value from the claims analysis by enabling NPI-powered media to extend coverage to target HCPs not accessible by the sales team.

Predictive targeting

Dynamic LeadGen uses Machine Learning to uncover referral patterns to precisely forecast where rare and specialty disease patients will go next - mitigating the impact of 'stale' leads and empowering biopharma to engage with healthcare providers proactively.

Expanded reach

Dynamic LeadGen goes beyond the limitations of traditional claims analysis by leveraging omnichannel media to engage with target practices and physicians that may be missed by conventional approaches - ensuring outreach is comprehensive and leaving no opportunity untapped.

End-to-end measurement

Dynamic LeadGen continuously measures the effectiveness of engagement by tracking a patient’s downstream actions, all reported via a streamlined dashboard.

THE AMBIT DIFFERENCE IS CLEAR

Legacy solutions	Dynamic LeadGen
STALE LEADS The lag time inherent in claims data poses challenges, especially for rare diseases where patient interactions with HCPs might be infrequent – leaving field teams chasing outdated leads.	PREDICTIVE & TIMELY Leveraging the power of ML/AI to map referral networks, Dynamic LeadGen forecasts where patients will go next, empowering biopharma to engage with healthcare providers proactively.
LOW YIELDS Only a fraction of the leads generated by traditional trigger models yield patients due to the limited reach of small, over-taxed field forces – leaving valuable opportunities untapped.	EXPANDED REACH Dynamic Lead-Gen extracts incremental value from claims data analysis through NPI-powered media – extending coverage to target HCPs beyond the reach of traditional sales teams.
BLACK BOX Traditional trigger-based models do not measure ROI or yield because they are limited to a file hand-off of retrospective claims analysis.	ALWAYS-ON MEASUREMENT Dynamic Lead-Gen continuously measures the effectiveness of engagement by tracking a patient’s downstream actions.

WHY AMBIT

Specialty & rare disease expertise

Ambit brings unparalleled expertise in specialty, rare, and ultra-rare diseases. Our team boasts a breadth and depth of experience that is unmatched, ensuring a nuanced understanding of the intricacies of these unique markets.

Ambit's commitment to supporting the entire rare and specialty disease ecosystem is rooted in an academic understanding of these conditions. Clients benefit from our comprehensive approach, where commercial support is seamlessly woven into the fabric of our academic insight, ensuring a holistic perspective.

Robust data capabilities

Ambit's strength lies in leveraging licensed longitudinal claims, affiliations, and Social Determinants of Health (SDOH) data. Our robust data capabilities extend further with the tokenization of additional data sources through Datavant, providing a comprehensive foundation for precision patient identification.

Ambit goes beyond its licensed data sources, allowing the integration of client-proprietary data via third-party agreements (TPAs). This flexibility ensures that our approach is tailored to the unique data landscape of each client, enhancing the precision and effectiveness of our solutions.

Award-winning analytics

Ambit’s Data and Analytics team prides itself in harnessing advanced analytics techniques including AI, machine learning, deep learning, Natural Language Processing (NLP), network and cluster analysis, and visualization to solve the most complex problems our clients face.

The team was recognized for its unique approach to modeling for patient finding as a part of the Global Genes Xcelerate RARE Open Science Data Challenge. The award for Best Computational Approach for Predicting a Diagnosis Based on Patient-Reported Data challenged the team to create machine learning algorithms to predict disease diagnoses based on the diagnostic journey of patients and their families.

AMBIT'S PATIENT FINDING PRODUCTS

Our patient-finding products engage both patients and HCPs through a combination of advanced data analytics, omnichannel marketing, and direct outreach through our team of Ambit Guides.

Our Product Development teams are at the forefront of using data and technology to develop transformative biopharma solutions for rare and specialty diseases at scale. Our passion lies in the intersection of strategy, data analytics, and cutting-edge technology, and we collaborate closely with our esteemed clients to tackle intricate challenges across pre-commercial and commercial landscapes.